Carlisle Companies Incorporated (CSL)

Current ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Total current assets US$ in thousands 1,926,300 3,408,100 2,245,000 2,150,900 2,209,300
Total current liabilities US$ in thousands 665,800 1,186,300 1,078,400 1,169,500 646,200
Current ratio 2.89 2.87 2.08 1.84 3.42

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,926,300K ÷ $665,800K
= 2.89

The current ratio of Carlisle Companies Incorporated has exhibited some fluctuations over the past five years. Starting at a robust 3.42 on December 31, 2020, the ratio declined to 1.84 on December 31, 2021, which could raise concerns about the company's ability to meet its short-term obligations with its current assets. However, the ratio improved in the following years, reaching 2.08 on December 31, 2022, and showing further improvement to 2.87 on December 31, 2023, indicating a healthier liquidity position. The current ratio remained relatively stable at 2.89 on December 31, 2024, suggesting that the company has maintained its ability to cover its short-term liabilities with its current assets.

Overall, while there have been fluctuations in the current ratio, the trend indicates that Carlisle Companies Incorporated has managed to strengthen its liquidity position over the years, which is generally viewed positively by creditors and investors as it signifies the company's ability to meet its short-term obligations comfortably.


Peer comparison

Dec 31, 2024

Company name
Symbol
Current ratio
Carlisle Companies Incorporated
CSL
2.89
West Pharmaceutical Services Inc
WST
2.79